Related Experiment Video
Updated: May 8, 2026
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Performance optimization of ultrashort antimicrobial peptides through backbone amide cyclization.
Ruoxin Tian1, Min Yang2, Kaixun Cao2
1Department of Molecular and Cell Biology, School of Life Sciences, University of Science and Technology of China, Hefei, 230027, China; State Key Laboratory of Genetic Evolution and Animal Models, Engineering Laboratory of Peptides of Chinese Academy of Sciences, Key Laboratory of Bioactive Peptides of Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, National Resource Center for Non-Human Primates, Kunming Institute of Zoology, National Research Facility for Phenotypic and Genetic Analysis of Model Animals (Primate Facility), Sino-African Joint Research Center, New Cornerstone Science Laboratory, Chinese Academy of Sciences, No. 17 Longxin Road, Kunming, Yunnan, 650201, China.
Researchers engineered ultrashort cyclic antimicrobial peptides (AMPs) with enhanced potency and stability. This novel approach combats antimicrobial resistance by stabilizing peptide structure for effective bacterial membrane targeting.
Area of Science:
- Biochemistry and Molecular Biology
- Medicinal Chemistry
- Microbiology
Background:
- Antimicrobial resistance (AMR) necessitates novel therapeutic strategies.
- Ultrashort antimicrobial peptides (AMPs) offer manufacturability but often lose activity due to conformational instability.
- A strategy to engineer stable, potent ultrashort AMPs is needed.
Purpose of the Study:
- To develop a conformational engineering strategy for ultrashort AMPs.
- To restore and enhance the antibacterial activity of minimized AMPs.
- To assess the therapeutic potential of engineered ultrashort cyclic AMPs.
Main Methods:
- Identified a minimal Trp/Lys/Arg-rich motif from a cathelicidin template (ZY4).
- Generated an ultrashort cyclic peptide (WKR-cyl) using backbone amide cyclization.
- Evaluated antibacterial potency, membrane selectivity, stability, and in vivo efficacy against MRSA.
Main Results:
- WKR-cyl demonstrated enhanced antibacterial potency, membrane selectivity, and proteolytic stability compared to linear analogs.
- Amide cyclization stabilized membrane-active conformations and increased hydrophobic interactions for efficient membrane insertion.
- WKR-cyl showed potent activity against MRSA, anti-biofilm effects, high plasma stability, minimal resistance induction, and therapeutic efficacy in murine models.
Conclusions:
- Backbone amide cyclization is an effective strategy to restore and enhance ultrashort AMP function.
- WKR-cyl exhibits promising characteristics for development as a clinically translatable anti-infective peptide.
- This approach addresses the challenge of conformational instability in minimized AMPs for combating AMR.
